SIGLEC1 enables straightforward assessment of type I interferon activity in inflammatory myopathies
Manuel Graf, Sae Lim von Stuckrad, Akinori Uruha, Jens Klotsche, Lydia Zorn-Pauly, Nadine Unterwalder, Thomas Buttgereit, Martin Krusche, Christian Meisel, Gerd R. Burmester, Falk Hiepe, Robert Biesen, Tilman Kallinich, Werner Stenzel, Udo Schneider, Thomas Rose
doi: https://doi.org/10.1101/2021.09.13.21263325
Manuel Graf
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, 10117 Berlin, Germany
Sae Lim von Stuckrad
2Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Pediatric Pneumology, Immunology and Critical Care Medicine and SPZ (Center for Chronically Sick Children), Augustenburger Platz 1, 13353 Berlin, Germany
Akinori Uruha
3Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Charitéplatz 1, 10117 Berlin, Germany
4Tokyo Metropolitan Neurological Hospital, Department of Neurology, 2-6-1 Musashidai, Fuchu-shi, Tokyo 183-0042, Japan
Jens Klotsche
5German Rheumatism Research Center Berlin – a Leibniz Institute (DRFZ), Charitéplatz 1, 10117 Berlin, Germany
Lydia Zorn-Pauly
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, 10117 Berlin, Germany
Nadine Unterwalder
6Labor Berlin – Charité Vivantes GmbH, Department of Immunology, Sylter Str. 2, 13353 Berlin, Germany
Thomas Buttgereit
7Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Dermatology and Allergy, Dermatological Allergology, Allergie-Centrum-Charité, Charitéplatz 1, 10117 Berlin, Germany
Martin Krusche
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, 10117 Berlin, Germany
Christian Meisel
6Labor Berlin – Charité Vivantes GmbH, Department of Immunology, Sylter Str. 2, 13353 Berlin, Germany
Gerd R. Burmester
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, 10117 Berlin, Germany
Falk Hiepe
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, 10117 Berlin, Germany
Robert Biesen
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, 10117 Berlin, Germany
Tilman Kallinich
2Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Pediatric Pneumology, Immunology and Critical Care Medicine and SPZ (Center for Chronically Sick Children), Augustenburger Platz 1, 13353 Berlin, Germany
5German Rheumatism Research Center Berlin – a Leibniz Institute (DRFZ), Charitéplatz 1, 10117 Berlin, Germany
Werner Stenzel
3Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Charitéplatz 1, 10117 Berlin, Germany
Udo Schneider
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, 10117 Berlin, Germany
Thomas Rose
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, 10117 Berlin, Germany
Posted September 16, 2021.
SIGLEC1 enables straightforward assessment of type I interferon activity in inflammatory myopathies
Manuel Graf, Sae Lim von Stuckrad, Akinori Uruha, Jens Klotsche, Lydia Zorn-Pauly, Nadine Unterwalder, Thomas Buttgereit, Martin Krusche, Christian Meisel, Gerd R. Burmester, Falk Hiepe, Robert Biesen, Tilman Kallinich, Werner Stenzel, Udo Schneider, Thomas Rose
medRxiv 2021.09.13.21263325; doi: https://doi.org/10.1101/2021.09.13.21263325
SIGLEC1 enables straightforward assessment of type I interferon activity in inflammatory myopathies
Manuel Graf, Sae Lim von Stuckrad, Akinori Uruha, Jens Klotsche, Lydia Zorn-Pauly, Nadine Unterwalder, Thomas Buttgereit, Martin Krusche, Christian Meisel, Gerd R. Burmester, Falk Hiepe, Robert Biesen, Tilman Kallinich, Werner Stenzel, Udo Schneider, Thomas Rose
medRxiv 2021.09.13.21263325; doi: https://doi.org/10.1101/2021.09.13.21263325
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (626)
- Anesthesia (162)
- Cardiovascular Medicine (2356)
- Dermatology (206)
- Emergency Medicine (377)
- Epidemiology (11744)
- Forensic Medicine (10)
- Gastroenterology (699)
- Genetic and Genomic Medicine (3713)
- Geriatric Medicine (347)
- Health Economics (632)
- Health Informatics (2383)
- Health Policy (928)
- Hematology (340)
- HIV/AIDS (776)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (397)
- Neurology (3473)
- Nursing (197)
- Nutrition (522)
- Oncology (1809)
- Ophthalmology (534)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (232)
- Palliative Medicine (66)
- Pathology (445)
- Pediatrics (1026)
- Primary Care Research (417)
- Public and Global Health (6120)
- Radiology and Imaging (1268)
- Respiratory Medicine (824)
- Rheumatology (379)
- Sports Medicine (320)
- Surgery (398)
- Toxicology (50)
- Transplantation (171)
- Urology (145)